Showing 1 - 6 results of 6 for search 'Bridgette M Collins-Burow', query time: 0.04s Refine Results
  1. 1
    Targeting Mcl-1 by a small molecule NSC260594 for triple-negative breast cancer therapy

    Targeting Mcl-1 by a small molecule NSC260594 for triple-negative breast cancer therapy by Shengli Dong, Margarite D. Matossian, Hassan Yousefi, Maninder Khosla, Bridgette M. Collins-Burow, Matthew E. Burow, Suresh K. Alahari

    Published 2023-07-01
    Get full text
    Article
  2. 2
    436 Examining the Role of Obesity and Leptin Signaling in Triple Negative Breast Cancer

    436 Examining the Role of Obesity and Leptin Signaling in Triple Negative Breast Cancer by Courtney Brock, Maryl K. Wright, Khoa Nguyen, Katherine Hebert, Madlin Alzoubi, Thomas Cheng, Bridgette M. Collins-Burow, Matthew E. Burow

    Published 2022-04-01
    Get full text
    Article
  3. 3
    Dataset of transcriptomic changes induced by naringenin treatment in MCF-7 breast cancer cellsGene Expression Omnibus

    Dataset of transcriptomic changes induced by naringenin treatment in MCF-7 breast cancer cellsGene Expression Omnibus by Van T. Hoang, Mackenzie L. Hawes, Jack R. Elliott, Steven Elliott, Binghao Zou, Stephen M. Boué, Brian G. Rowan, Bridgette M. Collins-Burow, Jorge A. Belgodere, Muralidharan Anbalagan, Elizabeth C. Martin, Matthew E. Burow

    Published 2025-04-01
    Get full text
    Article
  4. 4
    Lysine deacetylase inhibitors have low selectivity in cells and exhibit predominantly off‐target effects

    Lysine deacetylase inhibitors have low selectivity in cells and exhibit predominantly off‐target effects by Kiara E. Bornes, Marcus A. Moody, Thomas M. Huckaba, Megan C. Benz, Emily C. McConnell, Maryam Foroozesh, Van H. Barnes, Bridgette M. Collins‐Burow, Matthew E. Burow, Terry J. Watt, Tasha B. Toro

    Published 2025-01-01
    Get full text
    Article
  5. 5
    Obesity and leptin in breast cancer angiogenesis

    Obesity and leptin in breast cancer angiogenesis by Courtney B. Lagarde, Courtney B. Lagarde, Kapil Thapa, Nicole M. Cullen, Nicole M. Cullen, Mackenzie L. Hawes, Mackenzie L. Hawes, Khudeja Salim, Khudeja Salim, Megan C. Benz, Megan C. Benz, Sophie R. Dietrich, Sophie R. Dietrich, Sophie R. Dietrich, Brandon E. Burow, Bruce A. Bunnell, Elizabeth C. Martin, Elizabeth C. Martin, Bridgette M. Collins-Burow, Bridgette M. Collins-Burow, Ronald M. Lynch, Van T. Hoang, Van T. Hoang, Matthew E. Burow, Matthew E. Burow, Matthew E. Burow, Matthew E. Burow, Jennifer S. Fang, Jennifer S. Fang

    Published 2024-10-01
    Get full text
    Article
  6. 6
    Patient-Derived Xenografts as an Innovative Surrogate Tumor Model for the Investigation of Health Disparities in Triple Negative Breast Cancer

    Patient-Derived Xenografts as an Innovative Surrogate Tumor Model for the Investigation of Health Disparities in Triple Negative Breast Cancer by Margarite D. Matossian, Alexandra A. Giardina, Maryl K. Wright, Steven Elliott, Michelle M. Loch, Khoa Nguyen, Arnold H. Zea, Frank H. Lau, Krzysztof Moroz, Adam I. Riker, Steven D. Jones, Elizabeth C. Martin, Bruce A. Bunnell, Lucio Miele, Bridgette M. Collins-Burow, Matthew E. Burow

    Published 2020-09-01
    Get full text
    Article

Search Tools: